Awards & Advancement

GeoVax receives $3.6 million grant for HIV/AIDS vaccine program

Tuesday, August 16, 2011 10:28 AM

GeoVax Labs, a biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, has received a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.

More... »

Auxilium names Tursi chief medical officer

Tuesday, August 16, 2011 10:07 AM

Auxilium Pharmaceuticals has promoted Dr. James P. Tursi to chief medical officer. Tursi will report to Armando Anido, chief executive officer and president of Auxilium, and sit on the Auxilium Executive Committee in this role.

More... »

Siffert joins Avanir as senior VP, research and development

Tuesday, August 16, 2011 10:05 AM

Avanir Pharmaceuticals has named Dr. Joao Siffert senior vice president research and development. In this newly created role, Siffert will be responsible for leading all research and development activities.

More... »

Genelux names Mackey to board of directors

Tuesday, August 16, 2011 10:01 AM

Genelux, a privately held clinical stage biopharmaceutical company, has named Dr. Catherine J. Mackey to its board of directors.

More... »

Jennerex completes $8.6 million financing round

Monday, August 15, 2011 01:55 PM

Jennerex, a private clinical-stage biotherapeutics company, has completed a successful private placement financing round with gross proceeds of approximately $8.6 million.

More... »

O’Connell joins Marken as chief financial officer

Monday, August 15, 2011 01:52 PM

Marken, a life sciences supply chain management organization, has named Christopher O'Connell chief financial officer.

More... »

Marken names interim head of clinical trials distrubtion

Friday, August 12, 2011 10:16 AM

Marken, a global provider of clinical supply chain services, has named Frank J. Wright its interim president of the clinical trials distribution business unit. Wright will be responsible for growing the business, enhancing the team and identifying possible investment opportunities. He will also assist in recruiting the permanent president of the business unit.

More... »

Yaupon Therapeutics raises $14.4 million in Series D financing

Thursday, August 11, 2011 01:49 PM

Yaupon Therapeutics, a privately held pharmaceutical company, has raised $14.4 million through a Series D private placement of preferred stock. The new round includes prior investors Vivo Ventures, Palo Alto Investors and Burrill & Company, plus new investor, Aperture Venture Partners.

More... »

Verinata raises $46.5 million in Series C financing

Wednesday, August 10, 2011 12:53 PM

Verinata Health, a privately-held company dedicated to maternal and fetal health, has raised approximately $46.5 million in the finalization of its Series C financing. The funding was led by existing investors Mohr Davidow Ventures, Sutter Hill Ventures, and Alloy Ventures. Verinata plans to use the proceeds to fund continued research and development and subsequent commercialization of its non-invasive prenatal diagnostic test.

More... »

Ockham names Smith senior director

Wednesday, August 10, 2011 12:03 PM

Meghann Smith has joined Ockham as senior director, global therapeutic strategic development within the OckhamCROTM division. Smith will provide Ockham clients and functional teams with senior-level strategic guidance, risk mitigation analysis and solutions throughout the life-cycle of projects to help ensure study and program optimization on the regional, global and project/program levels with a primary therapeutic focus in hematology and oncology.

More... »